Definitive therapies for treating COVID-19, the disease caused by SARS-CoV-2, are still lacking
[1]. Worldwide deployment of potential effective vaccines might still take several months if not years
[2] and it remains unknown how they will impact transmission, including SARS-CoV-2 variants of concern. There is still an important need for therapeutic alternatives that help reduce mortality and protect the most vulnerable against infection.